News tagged ‘BasicResearch’ clear
- Dana-Farber researchers find blood test can provide fuller picture of cancer mutations in gastrointestinal stromal tumors than biopsy.
- Dana-Farber scientists found that pancreatic cancer cells' growth and spread are fueled by an unusual metabolic pathway that someday might be blocked with targeted drugs to control the deadly cancer.
Tags: BasicResearch, PancreaticCancer, TargetedTherapy
- A study by scientists at Dana-Farber Cancer Institute, the Broad Institute, and other research centers, may offer clues to why rates of esophageal adenocarcinomas (EACs) have risen so sharply. The findings, in Nature Genetics, point to an array of abnormal genes and proteins that may be lynchpins of EAC cell growth and therefore serve as targets for new therapies.
Tags: BasicResearch, Genomics, TargetedTherapy
- Dana-Farber scientists have linked genetic variants to the regulation of genes involved in breast cancer, including four genes not previously implicated in breast cancer, shedding new insights into the biology of breast cancer.
Tags: BasicResearch, BreastCancer, Genomics
- Ken Anderson, MD, briefed members of Congress and their legislative staffs on blood cancer care and research, and the importance of protecting and enhancing federal research funding.
Tags: BasicResearch, Grants, MultipleMyeloma
- Dana-Farber and Broad Institute researchers for the first time are able to show the past, present, and future of CLL tumors.
Tags: BasicResearch, Genetics, Leukemia
- Dana-Farber scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model. They say it holds promise for improved treatment of arthritis and other autoimmune disorders in people.
Tags: BasicResearch, ImmuneSystem
- Dana-Farber/Children's Hospital Cancer Center is one of the first three institutions to be named as a Center of Excellence by Alex's Lemonade Stand Foundation.
Tags: BasicResearch, ChildhoodCancer, Grants, Honors
- Dana-Farber and Broad Institute researchers have identified two mutations that collectively occur in 71 percent of malignant melanoma tumors. These highly "recurrent" mutations may be the most common mutations in melanoma cells found to date.
Tags: BasicResearch, Genomics, Melanoma
Showing 11-20 of 120 items